Literature DB >> 31583595

Astrocytes in Huntington's Disease.

Michelle Gray1.   

Abstract

Huntington's disease (HD) is a dominantly inherited neurodegenerative disease that results in motor, cognitive and psychiatric dysfunction. It is caused by a polyglutamine repeat expansion mutation in the widely expressed HTT protein. The clinical manifestations of HD have been largely attributed to the neurodegeneration of specific neuronal cell types in the brain. However, it has become clear that other cell types, including astrocytes, play important roles in the pathogenesis of HD. The mutant HTT (mHTT) protein is present in neuronal and non-neuronal cell types throughout the nervous system. Studies designed to understand the contribution of mHTT expression in non-neuronal cell types to HD pathogenesis has lagged considerably behind those focused on neurons. However, the role of astrocytes in HD has received more attention over the last 5-10 years. In this chapter we present an overview of HD and our current understanding of astrocytic involvement in this disease. We describe the neuropathological features of HD and provide evidence of morphological and molecular changes in mHTT expressing astrocytes. We review data from animal models and HD patients that implicate mHTT expressing astrocytes to the progression of HD.

Entities:  

Keywords:  Astrocytes; BDNF; Cholesterol; Excitotoxicity; Huntingtin

Mesh:

Year:  2019        PMID: 31583595     DOI: 10.1007/978-981-13-9913-8_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  Chemical interference with DSIF complex formation lowers synthesis of mutant huntingtin gene products and curtails mutant phenotypes.

Authors:  Ning Deng; Yun-Yun Wu; Yanan Feng; Wen-Chieh Hsieh; Jen-Shin Song; Yu-Shiuan Lin; Ya-Hsien Tseng; Wan-Jhu Liao; Yi-Fan Chu; Yu-Cheng Liu; En-Cheng Chang; Chia-Rung Liu; Sheh-Yi Sheu; Ming-Tsan Su; Hung-Chih Kuo; Stanley N Cohen; Tzu-Hao Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

2.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

3.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 4.  Epigenetic regulation in Huntington's disease.

Authors:  Jae Wook Hyeon; Albert H Kim; Hiroko Yano
Journal:  Neurochem Int       Date:  2021-05-24       Impact factor: 4.297

5.  Genetic Screen in Adult Drosophila Reveals That dCBP Depletion in Glial Cells Mitigates Huntington Disease Pathology through a Foxo-Dependent Pathway.

Authors:  Elodie Martin; Raheleh Heidari; Véronique Monnier; Hervé Tricoire
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 6.  Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.

Authors:  Julia Kaye; Terry Reisine; Steve Finkbeiner
Journal:  Fac Rev       Date:  2021-10-21

Review 7.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

8.  Huntingtin silencing delays onset and slows progression of Huntington's disease: a biomarker study.

Authors:  Hongshuai Liu; Chuangchuang Zhang; Jiadi Xu; Jing Jin; Liam Cheng; Xinyuan Miao; Qian Wu; Zhiliang Wei; Peiying Liu; Hanzhang Lu; Peter C M van Zijl; Christopher A Ross; Jun Hua; Wenzhen Duan
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

Review 9.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.